by PKD Foundation Staff | Dec 23, 2019 | Donations, PKD Foundation News
Published Dec. 23, 2019 We wish you a wonderful holiday season and a Happy New Year! To make a gift in 2019 Donate online at pkdfoundation.staging.wpengine.com/yearend Mail a check to: PKD Foundation 1001 E 101st Terrace Suite 220 Kansas City, MO 64131...
by PKD Foundation Staff | Dec 6, 2019 | Awareness, PKD Foundation News, Q and A, Research
Published December 6, 2019 A little over a month ago, Chris Rusconi joined PKD Foundation as its new Chief Research Officer. Over the past 30 days, Chris has been immersed in all things PKD from attending Kidney Week 2019 in Washington DC to the quarterly board...
by PKD Foundation Staff | Nov 19, 2019 | Advocacy, Awareness, PKD Foundation News, Research
Published November 21, 2019 Written by Elise Hoover, Director of Research The PKD Foundation (PKDF) has just returned from Kidney Week 2019 in Washington, D.C. The annual scientific meeting hosted by the American Society of Nephrology (ASN) ran Nov. 7–10. This is one...
by PKD Foundation Staff | Dec 28, 2018 | PKD Foundation News, Positivity
This year, we hit some incredible milestones as an organization and community. I’d like to thank patients, caregivers, volunteers, researchers, physicians and staff for all their time and efforts that contributed to the following achievements: In April, the Federal...
by PKD Foundation Staff | Apr 24, 2018 | ADPKD, PKD Foundation News, Research
Today is a historic day in providing hope to patients with polycystic kidney disease. We are excited to announce that the U.S. Food and Drug Administration (FDA) granted approval of JYNARQUE™ (tolvaptan) to be the first treatment in the United States for adult...
by PKD Foundation Staff | Feb 21, 2018 | PKD Foundation News
PKD parents, patients, researchers and advocates gathered together in Chicago in early February for the first meeting of the newly formed PKD in Children Council. As the PKD Foundation seeks to give hope and serve those affected by PKD, this Council was created to...
